Advertisement

Use of Experimental Models in the Study of Approaches to Treatment of Colorectal Cancer

  • Daniel P. GriswoldJr.
  • Thomas H. Corbett
Part of the Sloan-Kettering Institute Cancer Series book series (SKICS)

Abstract

Animal tumors have been widely used as models in studies of the etiology, behavior, and treatment of cancer of man. It is the last consideration that is of concern here, i.e., the development of optimal approaches to therapy through the use of experimental models. Many questions of the clinical oncologist cannot be answered from therapeutic trials in man because of the limitations imposed by ethics that preclude the use of certain controls and assay procedures. If, then, a totally empirical approach is to be avoided, the answers to those questions must come through the use of likely relevant animal tumors. Yet relevancy can often be determined only in retrospect. Nevertheless, experimentalists as well as clinicians have already recognized the need for better tumor models. It is hoped that their use will lead to improved therapeutic results as well as a better understanding of the nature of cancer growth and spread.

Keywords

Colon Tumor Animal Tumor Animal Tumor Model Human Colon Tumor Volume Doubling Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baserga, R., 1965, The relationship of the cell cycle to tumor growth and control of cell division: A review, Cancer Res. 25: 581–595.PubMedGoogle Scholar
  2. Bruce, W. R., Meeker, B. E., and Valeriote, F. A., 1966, Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents, J. Natl. Cancer Inst. 37: 233–245.PubMedGoogle Scholar
  3. Corbett, T. H., Griswold, D. P., Roberts, B. J., Peckham, J. C., and Schabel, F. M., Jr., 1975a, Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure, Cancer Res. 35: 2434–2439.PubMedGoogle Scholar
  4. Corbett, T. H., Griswold, D. P., Roberts, B. J., Peckham, J., and Schabel, F. M., Jr., I975b, A mouse colon tumor model for experimental therapy, Cancer Chemother. Rep. 5(2):169–186.Google Scholar
  5. Cortes, E. P., Holland, J. F., Wang, J. J., Sinks, L. F., Blom, J., Hansjurg, S., Bank, A., and Glidewell, 0., 1974, Amputation and adriamycin in primary osterosarcoma, N. Eng. J. Med. 291: 998–1000.CrossRefGoogle Scholar
  6. DeVita, V. T., Young, R. C., and Canellos, G. P., 1974, Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer, Cancer (Philadelphia) 35: 98–110.CrossRefGoogle Scholar
  7. Double, J. A., Ball, C. R., and Cowen, P. N., 1975, Transplantation of adenocarcinomas of the colon in mice, J. Natl. Cancer Inst. 54: 271–275.PubMedGoogle Scholar
  8. Fisher, B., Carbone, P:, Economou, S. G., Frelick, R., Glass, A., Lerner, H., Redmond, C., Zelen, M., Band, P., Katrych, D. L., Wolmark, W., and Fisher, E. R., 1975, L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer, a report of early findings, N. Eng. J. Med. 292: 117–122.Google Scholar
  9. Fortnér, J. G., Mahy, A. G., Schrodt, G. R., and Cotran, R. S., 1961, Transplantable tumors of the Syrian (golden) hamster. Parts I and II, Cancer Res. 21: 161–234.PubMedGoogle Scholar
  10. Fowler, J. F., 1966, Radiation biology as applied to radiotherapy, in: Current Topics in Radiation Google Scholar
  11. Research (M. Ebert and A. Howard, eds.), pp. 303–364, North-Holland, Amsterdam. Goldin, A., Venditti, J. M., Humphreys, S. R., and Mantel, N., 1956, Modification of treatment schedules in the management of advanced mouse leukemia with amethopterin, J. Natl. Cancer Inst. 17:203–212.Google Scholar
  12. Griswold, D. P., 1972, Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents, Cancer Chemother. Rep. Part 2 3:315–324. Griswold, D. P., Jr., 1975, The potential for murine tumor models in surgical adjuvant chemotherapy, Cancer Chemother. Rep. 5 (2): 187–204.Google Scholar
  13. Griswold, D. P., and Corbett, T. H., 1976, Breast tumor modeling for prognosis and treatment, in: Recent Results in Cancer Research, Vol. 57, pp. 42–58, Springer Verlag, Berlin.Google Scholar
  14. Griswold, D. P., Schabel, F. M., Wilcox, W. S., Simpson-Herren, L., and Skipper, H. E., 1968, Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC 26271) on primary and metastatic plasmacytoma in the hamster, Cancer Chemother. Rep. 52: 345–387.PubMedGoogle Scholar
  15. Hertz, R., Lewis, J., and Lippset, M., 1961, Five years experience with the chemotherapy of metastatic choriocarcinoma and related tropoblastic tumors in women, Am. J. Obstet. Gynecol. 82: 631.PubMedGoogle Scholar
  16. Horton, J., Hacker, B., Cunningham, T. J., and Sponzo, R. W., 1974, The chemotherapy of large-bowel cancer: Present status and future prospects, Digest. Dis. 19: 1040–1046.CrossRefGoogle Scholar
  17. Howeld, M. A., 1975, Diet as an etiological factor in the development of cancers of the colon and rectum, J. Chron. Dis. 28: 67–80.CrossRefGoogle Scholar
  18. Jaffe, N., Frei, E., Traggis, D., and Bishop, Y., 1974, Adjuvant methotrexate and citrovorumfactor treatment of osteogenic sarcoma, N. Eng. J. Med. 291: 994–997.CrossRefGoogle Scholar
  19. Karrer, K., Humphreys, S. R., and Goldin, A., 1967, An experimental model for studying factors which influence metastases of malignant tumors, Int. J. Cancer 2: 213–223.Google Scholar
  20. Laquer, G. L., 1965, The induction of intestinal neoplasms in rats with the glycoside of cycasin and its aglycone, Arch. Pathol. Anat. 340: 151–163.CrossRefGoogle Scholar
  21. Martin, D. S., Hayworth, P. E., and Fugmann, R. A., 1970, Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy and immunotherapy, Cancer Res. 30: 709–716.PubMedGoogle Scholar
  22. Mayo, J. G., Laster, W. R., Andrews, C. M., and Schabel, F. M., Jr., 1972, Success and failure in the treatment of solid tumors. III. “Cure” of metastatic Lewis lung carcinoma with methyl-CCNU (NSC 95441) and surgery-chemotherapy, Cancer Chemother. Rep. Part I 56: 183–195.Google Scholar
  23. McCall, D. C., and Cole, J. W. 1974, Transplantation of chemically induced adenocarcinomas of the colon in an inbred strain of rats, Cancer (Philadelphia) 33: 1021–1026.CrossRefGoogle Scholar
  24. Mendelsohn, M. L., 1960, The growth fraction: A new concept applied to tumors, Science 132: 1496.Google Scholar
  25. Moertel, C. G., 1973, Alimentary tract cancer XXIV-12: Large bowel, in: Cancer Medicine U. F. Holland and E. Frei, III, eds.), p. 1615, Lea and Febiger, Philadelphia.Google Scholar
  26. Moertel, C. G., 1975, Clinical management of advanced gastrointestinal cancer, Cancer (Philadelphia) 36: 675–682.CrossRefGoogle Scholar
  27. Moertel, C. G., Schutt, A. J., Hahn, R. G., and Reitemeir, R. J., 1975, Therapy of advance() colo-rectal cancer with a combination of 5-fluorouracil, methyl-1,3 cis(2-chloroethyl)-1nitrosourea, and vincristine, J. Natl. Cancer Inst. 54: 69–71.Google Scholar
  28. Morrow, R. H., Pike, M. C., and Kisule, A., 1967, Survival of Burkett’s lymphoma patients in Mulago Hospital, Uganda, Br. Med. J. 4: 323.Google Scholar
  29. Narisawa, T., Sato, T., Hayakawa, M., Sakuma, A., and Nakano, H., 1971, Carcinoma of the colon and rectum of rats by rectal infusion of N-methyl-N’-nitro-N-nitrosoguanidine, Gann 62: 231–234.PubMedGoogle Scholar
  30. Sandberg, J., and Goldin, A., 1971, Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents, Cancer Chemother. Rep. Part 1 55: 233–238.Google Scholar
  31. Schabel, F. M., Jr., 1969, The use of tumor growth kinetics in planning “curative” chemotherapy of advanced solid tumors, Cancer Res. 29: 2384–2389.PubMedGoogle Scholar
  32. Schabel, F. M., Jr., 1975a, Concepts for systemic treatment of micrometastases, Cancer (Philadelphia) 35: 15–24.CrossRefGoogle Scholar
  33. Schabel, F. M., Jr., 1975b, Animal models as predictive systems, in: Cancer Chemotherapy, pp. 323–355, Year Book Medical Publishers, Chicago.Google Scholar
  34. Sherlock, P., 1974, The gastroenterologist and gastrointestinal cancer, Digest. Dis. 19: 933–934.Google Scholar
  35. Shipley, W. U., Stanley, J. A., and Steel, G. G., 1975, Tumor size dependency in the radiation response of the Lewis lung carcinoma, Cancer Res. 35: 2488–2493.PubMedGoogle Scholar
  36. Silverberg, E., and Holeb, A. I., 1975, Major trends in cancer: 25-year survey, CA Cancer J. Clin. 25: 2–21.Google Scholar
  37. Skipper, H. E., 1968, Biochemical, biological, pharmacologic, toxicologic, kinetic and clinical (subhuman and human) relationships, Cancer (Philadelphia) 21: 600–610.CrossRefGoogle Scholar
  38. Skipper, H. E., 1971, Kinetics of mammary tumor cell growth and implications for therapy, Cancer (Philadelphia) 28: 1479–1499.CrossRefGoogle Scholar
  39. Skipper, H. E., 1973, Successes and failures at the preclinical level; where now? in: Seventh National Cancer Conference Proceedings, American Cancer Society.Google Scholar
  40. Skipper, H. E., and Schabel, F. M., Jr., 1973, Quantitative and Cytokinetic studies in experimental tumor models, in: Cancer Medicine ( J. F. Holland and E. Frei, III, eds.), Lea and Febiger, Philadelphia.Google Scholar
  41. Skipper, H. E., Schabel, F. M., Jr., and Wilcox, W. S., 1964, On the criteria and kinetics associated with “curability” of experimental leukemia, Cancer Chemother. Rep. 35: 1–111.Google Scholar
  42. Skipper, H. E., Schabel, F. M., Jr., Mellett, L. B., Montgomery, J. A., Wilkoff, L. J., Lloyd, H. H., and Brockman, R. W., 1970, Implications of biochemical cytokinetic pharmacologic and toxicologic relationships in the design of optimal therapeutic schedules, Cancer Chemother. Rep. Part 1 54: 431–450.Google Scholar
  43. Steel, G. G., 1967, Cell loss as a factor in the growth rate of human tumors, Eur. J. Cancer 3: 381–387.Google Scholar
  44. Steel, G. G., and Adams, K., 1975, Stem-cell survival and tumor control in Lewis lung carcinoma, Cancer Res. 35: 1530–1535.PubMedGoogle Scholar
  45. Tannock, I. F., and Steel, G. G., 1969, Quantitative techniques for study of the anatomy and function of small blood vessels in tumors, J. Natl. Cancer Inst. 42: 771–782.Google Scholar
  46. Thurnherr, N., Deschner, E. E., Stonehill, E. H., and Lipkin, M., 1973, Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine, Cancer Res. 33: 940–945.PubMedGoogle Scholar
  47. Triolo, V. A., 1964, Nineteenth century foundations of cancer researchorigins of experimental research, Cancer Res. 24: 4–27.PubMedGoogle Scholar
  48. Valeriote, F. A., and Van Putten, L. M., 1975, Proliferation-dependent cytotoxicity of anticancer agents: A review, Cancer Res. 35: 2619–2630.Google Scholar
  49. Van Putten, L. M., 1974, Are cell kinetic data relevant for the design of tumour chemotherapy schedules? Cell Tissue Kinet. 7: 493–504.PubMedGoogle Scholar
  50. Van Putten, L. M., and Lelieveld, P., 1970, Factors determining cell killing by chemotherapeutic agents in vivo. I. Cyclophosphamide, Eur. J. Cancer 6: 313–321.Google Scholar
  51. Wasserman, T. H., Comis, R. L., Handelsman, H., Penta, J. S., Slavik, M., Soper, W. T., and Carter, S. K., 1974, Tabular overview of cancer chemotherapy of solid tumors, in: Report of the Division of Cancer Treatment NCI, 1974, Vol. 2: Program Logic and Scientific Reports, DHEW, NIH, Bethesda, Md.Google Scholar
  52. Weisburger, J. H., 1971, Colon carcinogens: Their metabolism and mode of action, Cancer (Philadelphia) 28: 60–70.Google Scholar
  53. Wheeler, G. P., and Simpson-Herren, L., 1973, Effects of purines, pyrimidines, nucleosides, and chemically related compounds on the cell cycle, in: Drugs and the Cell Cycle( A. M. Zimmerman, G. M. Padilla, and I. L. Cameron, eds.), Academic Press, New York.Google Scholar
  54. Wilcox, W. S., Griswold, D. P., Laster, W. R., Schabel, F. M., Jr., and Skipper, H. E., 1965, Experimental evaluation of potential anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors, Cancer Chemother. Rep. 47: 27–39.PubMedGoogle Scholar
  55. Wilkoff, L. J., Wilcox, W. S., Burdeshaw, J. A., Dixon, G. J., and Dulmadge, E. A., 1967, Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells, J. Natl. Cancer Inst. 39: 965–976.PubMedGoogle Scholar
  56. Zubrod, G. G., 1972, Chemical control of cancer, Proc. Natl. Acad. Sci. USA 69: 1042–1047.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • Daniel P. GriswoldJr.
    • 1
  • Thomas H. Corbett
    • 1
  1. 1.Southern Research InstituteBirminghamUSA

Personalised recommendations